[go: up one dir, main page]

MX2010007579A - Preparacion nutriceutica o farmaceutica revestida con una liberacion de sustancia activa de impulsion mejorada. - Google Patents

Preparacion nutriceutica o farmaceutica revestida con una liberacion de sustancia activa de impulsion mejorada.

Info

Publication number
MX2010007579A
MX2010007579A MX2010007579A MX2010007579A MX2010007579A MX 2010007579 A MX2010007579 A MX 2010007579A MX 2010007579 A MX2010007579 A MX 2010007579A MX 2010007579 A MX2010007579 A MX 2010007579A MX 2010007579 A MX2010007579 A MX 2010007579A
Authority
MX
Mexico
Prior art keywords
meth
weight
weight based
acrylic
active substance
Prior art date
Application number
MX2010007579A
Other languages
English (en)
Inventor
Hans-Ulrich Petereit
Hema Ravishankar
Shraddha Bodinge
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of MX2010007579A publication Critical patent/MX2010007579A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención trata sobre una preparación farmacéutica o nutricéutica que consta de un núcleo que contiene una sustancia farmacéutica o nutricéuticamente activa y una sustancia que actúa en una forma moduladora con respecto a la liberación de las sustancias farmacéutica o nutricéuticamente activas; y una capa controladora que rodea el núcleo y consta de i) 55 a 92% por peso con base en el peso total de copolímeros (met) acrílicos presentes en la capa de un o una mezcla de una variedad de copolímeros de (met) acrilato compuesta de 80 a 98% por peso con base en el peso del copolímero (met) acrílico de unidades estructurales derivadas del C1 a C4 alquil ésteres del ácido (met) acrílico y 2 a 20% por peso con base en el peso del copolímero (met) acrílico de unidades estructurales derivado de monómeros de (met) acrilato con un grupo de amonio cuaternario en el radical alquilo; y ii) 8 a 45% por peso con base en el peso total de los copolímeros (met) acrílicos presentes en la capa de uno o una mezcla de una variedad de copolímeros de (met) acrilato compuesto por más de 5 a 59% por peso con base en el peso del copolímero o unidades estructurales derivadas del ácido acrílico o del ácido metacrílico y tabletas o cápsulas que constan de lo mismo.
MX2010007579A 2008-01-10 2008-02-01 Preparacion nutriceutica o farmaceutica revestida con una liberacion de sustancia activa de impulsion mejorada. MX2010007579A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN96CH2008 2008-01-10
PCT/EP2008/051238 WO2009086941A1 (en) 2008-01-10 2008-02-01 Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release

Publications (1)

Publication Number Publication Date
MX2010007579A true MX2010007579A (es) 2010-08-03

Family

ID=40527442

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010007579A MX2010007579A (es) 2008-01-10 2008-02-01 Preparacion nutriceutica o farmaceutica revestida con una liberacion de sustancia activa de impulsion mejorada.

Country Status (14)

Country Link
US (1) US9011907B2 (es)
EP (1) EP2227225B1 (es)
JP (1) JP2011509265A (es)
KR (1) KR101571179B1 (es)
CN (1) CN101903017B (es)
CA (1) CA2711474C (es)
ES (1) ES2715274T3 (es)
HU (1) HUE043474T2 (es)
IL (1) IL205550A (es)
MX (1) MX2010007579A (es)
PL (1) PL2227225T4 (es)
SI (1) SI2227225T1 (es)
TR (1) TR201902212T4 (es)
WO (1) WO2009086941A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2983409B1 (fr) * 2011-12-06 2013-12-27 Ethypharm Sa Comprime susceptible de lutter contre le detournement par voie injectable
AU2015317469B2 (en) 2014-09-19 2018-03-15 The Procter & Gamble Company Pulsed release phenylephrine dosage forms
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion
MX2019008440A (es) 2019-07-15 2021-01-18 Dva Farma Mexicana S A De C V Composiciones de recubrimientos en pelicula para tabletas con brillantez incrementada, procedimiento de preparacion y aplicacion.
AU2023366929A1 (en) 2022-10-25 2025-05-08 Veradermics, Incorporated Compositions and methods of use for modified release minoxidil
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8003805L (sv) 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
DK0386967T3 (da) 1989-03-10 1995-11-20 Yamanouchi Pharma Co Ltd Coatingmateriale til styring af lægemiddelafgivelse i langtidsvirkende formuleringer
JPH0674206B2 (ja) * 1989-12-28 1994-09-21 田辺製薬株式会社 放出制御型製剤およびその製法
JPH07112932A (ja) * 1993-08-27 1995-05-02 Mitsui Toatsu Chem Inc 徐放性医薬製剤
JPH08143476A (ja) * 1994-11-18 1996-06-04 Japan Tobacco Inc 薬物放出制御膜及び固形製剤
DE19845358A1 (de) 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
KR20040018463A (ko) 2001-07-16 2004-03-03 아스트라제네카 아베 양성자 펌프 억제제 및 제산제를 함유하는 제약 제제
DE10250543A1 (de) 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
CA2543689A1 (en) 2003-10-31 2005-05-12 Hexal Ag Pharmaceutical actve-ingredient-containing formulation with coating
DE10353186A1 (de) 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz
DE10353196A1 (de) 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix
EP1863453A2 (en) 2005-03-29 2007-12-12 Evonik Röhm GmbH Multiparticulate pharmaceutical form comprising pellets with a substance having a modular effect in relation to active ingredient release
CN101484147B (zh) * 2006-08-18 2015-07-08 赢创罗姆有限责任公司 对于具有水中良好溶解性的活性成分具有受控的活性成分释放性的药物组合物
WO2008027993A2 (en) 2006-08-31 2008-03-06 Eurand, Inc. Drug delivery systems comprising solid solutions of weakly basic drugs
DE102007009243A1 (de) 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit einer Wirkstoff-Matrix und einem Polymerüberzug, sowie ein Verfahren zur Herstellung der Pellets

Also Published As

Publication number Publication date
CN101903017B (zh) 2014-12-24
KR101571179B1 (ko) 2015-11-23
IL205550A (en) 2017-06-29
BRPI0822140A8 (pt) 2022-07-05
PL2227225T3 (pl) 2019-05-31
EP2227225A1 (en) 2010-09-15
US9011907B2 (en) 2015-04-21
EP2227225B1 (en) 2018-11-14
BRPI0822140A2 (pt) 2019-10-01
CA2711474C (en) 2016-03-29
ES2715274T3 (es) 2019-06-03
HUE043474T2 (hu) 2019-08-28
TR201902212T4 (tr) 2019-06-21
KR20100103564A (ko) 2010-09-27
CN101903017A (zh) 2010-12-01
JP2011509265A (ja) 2011-03-24
IL205550A0 (en) 2010-12-30
US20100291202A1 (en) 2010-11-18
SI2227225T1 (sl) 2019-04-30
PL2227225T4 (pl) 2019-05-31
WO2009086941A1 (en) 2009-07-16
CA2711474A1 (en) 2009-07-16

Similar Documents

Publication Publication Date Title
MX2013014142A (es) Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol.
WO2007006353A3 (de) Verwendung eines teilneutralisierten, anionischen (meth) acrylat-copolymers als uberzug fur die herstellung einer arzneiform mit einer wirkstofffreisetzung bei erniedrigten ph-werten
MX2010007579A (es) Preparacion nutriceutica o farmaceutica revestida con una liberacion de sustancia activa de impulsion mejorada.
IL167334A (en) Multilayer dosage forms which contain active substances and which comprise a neutral core and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers
ATE553754T1 (de) Pharmazeutische zusammensetzung mit kontrollierter wirkstoffabgabe für wirkstoffe mit guter löslichkeit in wasser
WO2005046649A3 (de) Mehrschichtige arzneiform, enthaltend eine in bezug auf die wirkstoffreigabe modularisch wirkende substanz
UA103844C2 (ru) Фармацевтический состав, который содержит в матрице, которая подвергается эрозии, один или более эфиров фумаровой кислоты
WO2000019984A3 (de) Überzogene arzneiformen mit kontrollierter wirkstoffabgabe
MX369648B (es) Poli (met) acrilato basados en microcapsulas que contienen feromonas.
RU2011102777A (ru) Частицы с покрытием, содержащие фармацевтически активные агенты
ES2531252T3 (es) Copolímeros aleatorios de metacrilatos y acrilatos
MY147827A (en) Pharmaceutical solid preparation
IL180849A0 (en) Medicament in a multilayer form
ES2720952T3 (es) Composiciones adhesivas transdérmicas, dispositivos y métodos
MX376383B (es) Composicion farmaceutica o nutraceutica con resistencia contra la influencia del etanol
MX2010007578A (es) Preparacion nutriceutica o farmaceutica revestida con una liberacion acelerada controlada de sustancia activa.
MX2012001177A (es) Composicion en polvo o granulada que consta de un copolimero, una sal de un acido graso monocarboxilico y un acido graso monocarboxilico y/o un alcohol graso.
MX2015010449A (es) Composicion farmaceutica multiparticulada que comprende una multitud de dos clases de granulos.
TW200635963A (en) Partially neutralized anionic (meth)acrylate copolymer
RU2012140651A (ru) Фармацевтический или нутрицевтический состав
UA93530C2 (ru) Композиция c пролонгированным высвобождением активного вещества, способ ee получения и применения
MX2021010914A (es) Forma de dosificacion que comprende una matriz polimerica.

Legal Events

Date Code Title Description
FG Grant or registration